ACCESS RHEUMATOLOGY MAGAZINE
The official publication of RAN (Rheumatology Access Network)
Media Kit
BRAND MISSION
We believe the ever-changing and complex landscape of drug access, along with the increasing therapeutic options, requires a go-to source of information related specifically to access.
Access Rheumatology aims to educate and empower biologic coordinators and prior authorization specialists by informing them of the complex and ever-changing drug and patient access landscape. Readers are engaged with editorial and lifestyle content equally suitable for rheumatology patients, so they too may gain a better sense of therapies and the patient service programs that can assist in their treatment journey.
%
of readers say advertisements influence their consideration of the associated program
%
actively seek out ads that align with their interest in access-related articles
Audiences Served:
Primary – Biologic Coordinators and Prior Authorization Specialists
Secondary – Prescribers and the patients they treat
Circulation:
RAN membership and 5,000 Rheumatology prescribers*
*qualified list origin: profiled audiences based on market therapy data
2025 Quarterly Production Schedule:
March/April
June/July
August/September
November/December
Insertion Rates and Programs:
| Insertion Rates | 1 Page | 2+ Pages |
| 1x-2x | $4,000 | $5,000 |
| 3x-4x | $3,500 | $4,150 |
No charge for full PI pages
| Premium Placements | Price |
| Outside back cover | $8,000 |
| Inside back cover | $7,000 |
| Inside front cover | $7,250 |
| 1st after TOC | $5,500 |
| Cover tip | from $10,500 |
| Polybag | from $14,500 |
| BC Round Table | $14,500 |
| – Collaborate with RAN advisors to generate brand insights and frontline market feedback while generating content for patient programs to be written and placed in print. | |
| Magazine Editorial | $12,500 |
| – Showcase your drug access program through an editorial that offers a peer-to-peer overview of its benefits and best practices for biologic coordinators and prior authorization specialists. | |